Share

In This Section

Home / Blurb / Discussion Detail

Learn How LAG-3 Helps Tumors Evade the Immune System and Why Inhibiting It May Enhance Existing Immunotherapies

Published: September 26, 2024

Labcorp-Oncology-578x80

Could targeting LAG-3 take cancer immunotherapy to the next level? Dr. Sabi Pabla and Dr. Eric Severson share insights on this promising immune biomarker in the latest Labcorp Perspectives: Oncology interview.
Listen Here